Uncommon Presentation of Cytomegalovirus Encephalitis in an Immunocompetent Host: A Case Report
View abstract on PubMed
Summary
This summary is machine-generated.Cytomegalovirus (CMV) encephalitis, though rare in immunocompetent individuals, can present without typical signs. Early diagnosis via PCR and prompt ganciclovir treatment are crucial for recovery.
Area Of Science
- Neurology
- Infectious Diseases
- Virology
Background
- Cytomegalovirus (CMV) encephalitis is uncommon in immunocompetent individuals.
- Diagnosis is often difficult due to atypical or absent characteristic imaging and laboratory findings.
Purpose Of The Study
- To highlight a case of CMV encephalitis in an immunocompetent host.
- To emphasize the importance of considering CMV in unexplained encephalitis.
Main Methods
- A case report of a 68-year-old immunocompetent male with progressive encephalopathy.
- Utilized magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) analysis, and CMV deoxyribonucleic acid (DNA) detection via polymerase chain reaction (PCR).
Main Results
- Initial MRI and CSF studies were unremarkable.
- CMV DNA was detected in CSF and blood via PCR.
- The patient showed significant improvement after a 14-day course of intravenous ganciclovir.
Conclusions
- CMV encephalitis should be considered in unexplained encephalitis cases, even in immunocompetent patients with normal imaging.
- Early PCR testing for CMV DNA is vital for timely diagnosis.
- Prompt antiviral therapy, such as ganciclovir, leads to favorable outcomes.
Related Concept Videos
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

